Results of a phase 2 trial of HGS-ETR1 (Agonistic human monoclonal antibody to TRAIL receptor 1) in subjects with relapsed/refractory non-Hodgkin's lymphoma (NHL) Meeting Abstract


Authors: Younes, A.; Vose, J. M.; Zelenetz, A. D.; Smith, M. R.; Burris, H.; Ansell, S.; Klein, J.; Kumm, E.; Czuczman, M.
Abstract Title: Results of a phase 2 trial of HGS-ETR1 (Agonistic human monoclonal antibody to TRAIL receptor 1) in subjects with relapsed/refractory non-Hodgkin's lymphoma (NHL)
Meeting Title: 47th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 106
Issue: 11 Pt. 1
Meeting Dates: 2005 Dec 10-13
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2005-11-01
Start Page: 146A
End Page: 147A
Language: English
ACCESSION: WOS:000233426000490
PROVIDER: wos
PUBMED: 16342400
DOI: 10.1182/blood.V106.11.489.489
Notes: --- - Meeting Abstract:489 - 47th Annual Meeting of the American-Society-of-Hematology - DEC 10-13, 2005 - Atlanta, GA - "1" - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz